Role of endocrine factors in autistic spectrum disorders

Pediatric Clinics of North America

Volumn 59, Issue 1, 2012, Pages 75-88

  Tareen, Ruqiya Shama ^a,b   Kamboj, Manmohan K ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Kalamazoo Center for Medical Studies   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Autism; Autism spectrum disorders; Endocrine factors; Endocrine hormones

Indexed keywords

APELIN; CORTISONE; ENDOCRINE DISRUPTOR; ESTROGEN; GROWTH FACTOR; GROWTH HORMONE; HYDROCORTISONE; MELATONIN; NEUROTENSIN; OXYTOCIN; SECRETIN; TESTOSTERONE; THYROID HORMONE; VASOPRESSIN; VITAMIN D;

AUTISM; AUTOIMMUNE DISEASE; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM DISEASES; FEMALE; HORMONES; HUMANS; INFANT; MALE; NEUROPEPTIDES; RISK FACTORS;

EID: 84856274333     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.10.013     Document Type: Review

References (72)

1. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism. Pediatrics 2004, 113(5):72-86.
2. Leudar I., Costa A., Francis D. Theory of mind: a critical assessment. Theory Psychol 2004, 14:571.
3. Critchley H.D., Daly E.M., Bullmore E.T., et al. The functional neuroanatomy of social behavior: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 2000, 123:2203-2212.
4. Schulkin J. Autism and the amygdala: an endocrine hypothesis. Brain Cogn 2007, 65:87-99.
5. Riikonen R., Makkonen I., Vanhala R., et al. Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. Dev Med Child Neurol 2006, 48(9):751-755.
6. Riikonen R. Insulin-like growth factors: neurobiological regulators of brain growth in autism. Current Clinical Neurology 2008, 3:233-244.
7. Aylward E.H., Minshew N.J., Field K., et al. Effects of age on brain volume and head circumference in autism. Neurology 2002, 59(2):175-183.
8. Mills J.L., Hediger M.L., Molloy C.A., et al. Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clin Endocrinol (Oxf) 2007, 67(2):230-237.
9. Marz K.D., Dixon J., Dumont-Mathieu T. Accelerated head and body growth in infants later diagnosed with autism spectrum disorders: a comparative study of optimal outcome children. JChild Neurol 2009, 24(7):833-845.
10. Young L.J., Pitkow L.J., Feguson J.N. Neuropeptides and social behavior: animal models relevant to autism. Mol Psychiatry 2002, 7:S38-S39.
11. Ebstein R.P., Israel S., Lerer E., et al. Arginine vasopressin and oxytocin modulate social behavior. Ann N Y Acad Sci 2009, 1167:87-102.
12. Gregory S.G., Connelly J.J., Towers A.J., et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 2009, 7:62.
13. Gurrieri F., Neri G. Defective oxytocin function: a clue to understanding the cause of autism?. BMC Med 2009, 7:63.
14. Modahl C., Green L., Fein D., et al. Plasma oxytocin levels in autistic children. Biol Psychiatry 1998, 43(4):270-277.
15. Hollander E., Novotny S., Hanratty M., et al. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 2003, 28(1):193-198.
16. Hollander E., Bartz J., Chaplin W., et al. Oxytocin increases retention of social cognition in autism. Biol Psychiatry 2007, 61(4):498-503.
17. Heinrichs M., von Dawans B., Domes G. Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol 2009, 30(4):548-557.
18. Egashira N., Mishima K., Iwasaki K., et al. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions. JPharm Sci 2009, 109(1):44-49.
19. Donaldson Z.R., Young L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008, 322(5903):900-904.
20. Thompson R.R., George K., Walton J.C., et al. Sex specific influences of vasopressin on human social communication. Proc Natl Acad Sci USA 2006, 103(20):7889-7894.
21. Bartz J.A., Hollander E. The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Horm Behav 2006, 50(4):518-528.
22. Bartz J.A., Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders. Prog Brain Res 2008, 170:451-462.
23. Boso M., Emanuele E., Politi P., et al. Reduced plasma apelin levels in patients with autistic spectrum disorder. Arch Med Res 2007, 38(1):70-74.
24. Johnson K.P., Malow B.A. Sleep in children with autism spectrum disorders. Curr Neurol Neurosci Rep 2008, 8(2):155-161.
25. Limoges E., Mottron L., Bolduc C., et al. Atypical sleep architecture and the autism phenotype. Brain 2005, 128:1049-1061.
26. Melke J., Botros H.J., Chaste P., et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2008, 13(1):90-98.
27. Jonsson L., Ljunggren E., Bremer A., et al. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med Genomics 2010, 3:10.
28. Toma C., Rossi M., Sousa I., et al. Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations. Mol Psychiatry 2007, 12(11):977-979.
29. Giannotti F., Cortesi F., Cerquiglini A., et al. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. JAutism Dev Disord 2006, 36(6):741-753.
30. Sanchez-Barceló E.J., Mediavilla M.D., Reiter R.J. Clinical uses of melatonin in pediatrics. Int J Pediatr 2001, 2011:892624.
31. Anderson I.M., Kaczmarska J., McGrew S.G., et al. Melatonin for insomnia in children with autism spectrum disorders. JChild Neurol 2008, 23(5):482-485.
32. Colborn T. Neurodevelopment and endocrine disruption. Environ Health Perspect 2004, 112(9):944-949.
33. Howdeshell K.L. Amodel of the development of the brain as a construct of the thyroid system. Environ Health Perspect 2002, 110:337-348.
34. Morreale de Escobar G., Obregon M.J., Escobar de Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004, 151:U25-U37.
35. Miyuki S., Kanai H., Xu X., et al. Review of animal models for autism: implication of thyroid hormone. Congenit Anom 2006, 46(1):1-9.
36. Fries E., Dettenborn L., Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol 2009, 72(1):67-73.
37. Brosnan M., Turner-Cobb J., Munro-Naan Z., et al. Absence of a normal cortisol awakening response (CAR) in adolescent males with Asperger syndrome (AS). Psychoneuroendocrinology 2009, 34(1):1095-1100.
38. Zinke K., Fries E., Kliegel M., et al. Children with high-functioning autism show a normal awakening response (CAR). Psychoneuroendocrinology 2010, 35(1):1578-1582.
39. Hamza R.T., Hewedi D.H., Ismail M.A. Basal and adrenocorticotropic hormone stimulated plasma cortisol levels among Egyptian autistic children: relation to disease severity. Ital J Pediatr 2010, 36:71.
40. Corbett B.A., Mendoza S., Wegelin J.A., et al. Variable cortisol circadian rhythm in children with autism and anticipatory stress. JPsych Neurosci 2008, 33(3):227-234.
41. Corbett B.A., Schupp C.W., Levine S., et al. Comparing cortisol, stress and sensory sensitivity in children with autism. Autism Res 2009, 2(1):39-49.
42. Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 2002, 6(6):248-254.
43. Henningsson S., Jonsson L., Ljunggren E., et al. Possible association between the androgen receptor gene and autism spectrum disorder. Psychoneuroendocrinology 2009, 34(5):752-761.
44. Hönekopp J. Relationships between digit ratio 2D:4D and self-reported aggression and risk taking in an online study. Pers Individ Dif 2011, 51:77-80.
45. Hönekopp J., Bartholdt L., Beier L., et al. Second to fourth digit length ratio (2D:4D) and adult sex hormone levels: new data and a meta-analytic review. Psychoneuroendocrinology 2007, 32(4):313-321.
46. Auyeung B., Taylor K., Hackett G., et al. Foetal testosterone and autistic traits in 18 to 24-month-old children. Mol Autism 2010, 1(1):11.
47. Ingudomnukul E., Baron-Cohen S., Wheelright S., et al. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 2007, 51(5):597-604.
48. Choleris E., Gustafsson J.A., Korach K.S., et al. An estrogen dependent micronet mediating social recognition: a study with oxytocin- and estrogen receptor-alpha and -beta knockout mice. Proc Natl Acad Sci USA 2003, 100(10):6192-6197.
49. Chapter M.C., White C.M., DeRidder A., et al. Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies. Pharmacol Ther 2010, 125(1):39-54.
50. Horvath K., Papadimitriou J.C., Rabsztyn A., et al. Gastrointestinal abnormalities in children with autistic disorder. JPediatr 1999, 135(5):559-563.
51. Nishijima I., Yamagata T., Spencer C.M., et al. Secretin receptor-deficient mice exhibit impaired synaptic plasticity and social behavior. Hum Mol Genet 2006, 15(21):3241-3250.
52. Angelidou A., Francis K., Vasiad M., et al. Neurotensin is increased in serum of young children with autistic disorder. JNeuroinflammation 2010, 7:58.
53. Hill J., Cuasay K., Abebe D. Vasoactive intestinal peptide antagonist treatment during mouse embryogenesis impairs social behavior and cognitive function of adult male offspring. Exp Neurol 2007, 206(1):101-113.
54. Dealberto M.J. Prevalence of autism according to maternal immigrant status and ethnic origin. Acta Psychiatr Scand 2011, 123(5):339-348.
55. Humble M.B. Vitamin D, light and mental health. JPhotochem Photobiol B 2010, 101(2):142-149.
56. Grant W.B., Soles C.M. Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermatoendocrinol 2009, 1(4):223-228.
57. Fernell E., Barnevik-Olsson M., Bågenholm G. Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatr 2010, 99(5):743-747.
58. Freeman S.J., Roberts W., Daneman D. Diabetes and autism: is there a link?. Diabetes Care 2005, 28(4):925-926.
59. Devendra D., Liu E., Eisenbarth G.S. Type 1 diabetes: recent developments. BMJ 2004, 328(7442):750-754.
60. Bertrand J., Mars A., Boyle C., et al. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 2001, 108(5):1155-1161.
61. Denney D.R., Frei B.W., Gaffney G.R. Lymphocyte subsets and interleukin-2 receptors in autistic children. JAutism Dev Disord 1996, 26(1):87-97.
62. Atladóttir H.O., Pedersen M.G., Thorsen P., et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009, 124(2):687-694.
63. Comi A.M., Zimmerman A.W., Frye V.H., et al. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. JChild Neurol 1999, 14(6):388-394.
64. Mouridsen S.E., Rich B., Isager T., et al. Autoimmune diseases in parents of children with infantile autism: a case-control study. Dev Med Child Neurol 2007, 49(6):429-432.
65. Harjutsalo V., Tuomilehto J. Type 1 diabetes and autism: is there a link?. Diabetes Care 2006, 29(2):484-485.
66. Román G.C. Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents. JNeurol Sci 2007, 262(1-2):15-26.
67. Hashimoto T., Aihara R., Tayama M., et al. Reduced thyroid-stimulating hormone response to thyrotropin-releasing hormone in autistic boys. Dev Med Child Neurol 1991, 33(4):313-319.
68. Soldin O.P., Lai S., Lamm S.H., et al. Lack of a relation between human neonatal thyroxine and pediatric neurobehavioral disorders. Thyroid 2003, 13(2):193-198.
69. Campbell M., Small A.M., Hollander C.S., et al. Acontrolled crossover study of triiodothyronine in autistic children. JAutism Child Schizophr 1978, 8(4):371-381.
70. Abbassi V., Linscheid T., Coleman M. Triiodothyronine (T3) concentration and therapy in autistic children. JAutism Child Schizophr 1978, 8(4):383-387.
71. Windham G.C., Zhang L., Gunier R., et al. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect 2006, 114(9):1438-1444.
72. Chang S., Crothers C., Lai S., et al. Pediatric neurobehavioral diseases in Nevada counties with respect to perchlorate in drinking water: an ecological inquiry. Birth Defects Res A Clin Mol Teratol 2003, 67(10):886-892.